Attendee Demographics + Event Features
Lead Generation Opportunities
Sponsor & Exhibitor Portal
2017 Archived Content
2017 Speaking Faculty
Hinrich Abken, Ph.D., Professor & Head, Research, Molecular Medicine, University of Cologne
Amir R. Aref, Ph.D., Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School
Roy D. Baynes, M.D., Ph.D., Senior Vice President and Head, Global Clinical Development, CMO, Merck Sharp & Dohme
Stephen Beers, Ph.D., Associate Professor, Cancer Sciences Unit, Faculty of Medicine, University of Southampton
Chiara Bonini, Ph.D., Università Vita-Salute San Raffaele and Ospedale San Raffaele, Milan
Kerry Chester, Ph.D., Professor, UCL Cancer Institute
Shaun Cordoba, Ph.D., Research Scientist, Autolus
Angus Dalgleish, M.D., Professor, Oncology, St. George’s University of London
John Desjarlais, Ph.D., CSO, Xencor, Inc.
Joseph Dukes, Ph.D., Head, Preclinical Biology, Cell Biology, Immunocore Ltd.
Lindy Durrant, Ph.D., Professor, Cancer Immunotherapy, University of Nottingham; Joint CEO & CSO, Scancell
Andrea van Elsas, Ph.D., CSO, Aduro Biotech Europe
Zelig Eshhar, Ph.D., Chair, Cancer Immunotherapy, Research and Development, Sourasky Medical Center, Tel Aviv
David Feltquate, M.D., Ph.D., Vice President, Oncology Development, Bristol-Myers Squibb
Kandeepan Ganeshalingam, M.D., Executive Director, Oncology Therapeutic Area Head, European Clinical Development, Merck Sharp & Dohme
Tariq Ghayur, Ph.D., Distinguished Research Fellow, DVD-Ig and Novel Biologics, Global Biologics, AbbVie, Inc.
David Gilham, Ph.D., Vice President, Research & Development, Celyad S.A.
Bruno Gomes, Ph.D., Director, Tumour Immunology, Iteos Therapeutics
Lucie Heinzerling, M.D., Ph.D., MPH, Head of Dermatooncology, University Hospital of Erlangen
Lana Kandalaft, Pharm.D., Ph.D., Assistant Professor & Director, Center for Experimental Therapeutics, Department of Oncology, University of Lausanne; Tenure Track Assistant Professor, Ludwig Cancer Research Lausanne Branch
Bo Kara, Ph.D., Head, Process Development, Cell Gene Therapy CMC, GlaxoSmithKline
Maria Karasarides, Ph.D., Senior Director, Immuno-Oncology, Global Medicines Development, AstraZeneca
Ioannis Karydis, D.Phil., MRCP, Associate Professor, Oncology, Cancer Sciences Unit, University of Southampton
Christian Klein, Ph.D., Distinguished Scientist, Head, Oncology Programs, Cancer Immunotherapy Discovery, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich
John Maher, M.D., Ph.D., Consultant and Senior Lecturer, Immunology, Cancer Studies, King’s College London
Ryan McCoy, Eng.D., MEng, Senior Process Development Scientist, Industrialisation Group, Cell and Gene Therapy, Catapult
Alan Melcher, M.D., Ph.D., Professor, Translational Immunotherapy, The Institute of Cancer Research, London
Paul Moore, Ph.D., Vice President, Cell Biology and Immunity, Macrogenics, Inc.
Dario Neri, Ph.D., Professor, Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich
Christian Ottensmeier, M.D., Ph.D., Professor, Experimental Cancer Medicine, University of Southampton
Mark Paris, Ph.D., Technical Liaison, Mitra Biotech
Madhusudan Peshwa, Ph.D., CSO, MaxCyte
Christine Rothe, Ph.D., Vice President, Discovery & Alliance Management, Pieris Pharmaceuticals, Inc.
Catherine Sabatos-Peyton, Ph.D., Senior Investigator II, Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research (NIBR)
Maike Schmidt, Ph.D., Scientist and Group Leader, Cancer Immunology, Genentech, Inc.
Katherine J. Seidl, Ph.D., Director, Immunotherapy, bluebird bio
Armin Sepp, Ph.D., Senior Scientific Investigator, Systems Modeling and Translational Biology, GlaxoSmithKline
Andrew Sewell, Ph.D., Professor, Institute of Infection & Immunity, Cardiff University School of Medicine
Daniel E. Speiser, M.D., Professor, Clinical Tumor Biology & Immunotherapy, Department of Oncology, University of Lausanne
Hans Stauss, M.D., Ph.D., Professor and Director, Immunity & Transplantation, University College London
Catelijne Stortelers, Ph.D., Senior Project Leader, Technology, Discovery, Ablynx NV
Stefan Symeonides, Ph.D., Senior Lecturer, Experimental Cancer Medicine, Edinburgh Cancer Research Centre, University of Edinburgh
Sebastian Theurich, M.D., Lecturer, Internal Medicine, Hematology and Oncology, University Hospital Cologne, Germany
Martin Treder, Ph.D., CSO, Affimed
Bob Uger, Ph.D., CSO, Trillium Therapeutics, Inc.
Frederick Arce Vargas, Ph.D., Haematology, University College London Cancer Institute
Nicolai Wagtmann, Ph.D., Executive Vice President and CSO, Innate Pharma
Jon Wigginton, M.D., Senior Vice President, Clinical Development & CMO, MacroGenics
Robert W. Wilkinson, Ph.D., Director, Oncology Research, MedImmune Ltd.